SMTL ID : 4nz2.2 (1 other biounit)

Crystal structure of CYP2C9 in complex with an inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

monomer

Ligands

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 25 residues within 4Å: Chain A: R.78, I.93, V.94, W.101, R.105, L.275, A.278, G.279, T.282, T.283, T.286, Q.337, L.342, L.343, S.346, L.347, H.349, P.408, F.409, S.410, R.414, C.416, V.417, G.418, A.422 19 PLIP interactions: 18 interactions with chain A, 1 Ligand-Water interactions Hydrophobic interactions: A:I.93, A:V.94, A:L.275, A:L.342, A:L.343, A:L.347, A:F.409, A:A.422 Hydrogen bonds: A:V.94, A:S.346, A:S.410, A:S.410 Salt bridges: A:R.78, A:R.78, A:R.105, A:H.349, A:R.414 Metal complexes: A:C.416, H2O.6

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 7 residues within 4Å: Chain A: F.81, T.345, S.346, L.347, P.348, F.457 Ligands: SO4.3 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.345

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 4 residues within 4Å: Chain A: L.189, L.347 Ligands: GOL.2, 2QJ.4 2 PLIP interactions: 2 interactions with chain A Water bridges: A:L.189, A:F.457

1 x 2QJ: (2R)-N-{4-[(3-bromophenyl)sulfonyl]-2-chlorophenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide(Non-covalent)

2QJ.4: 16 residues within 4Å: Chain A: A.87, N.88, F.95, N.185, I.186, L.189, L.214, V.218, G.277, E.281, T.282, T.285, L.343, L.347, A.458 Ligands: SO4.3 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.186, A:I.186, A:T.282, A:A.458 Hydrogen bonds: A:N.88 Halogen bonds: A:A.87, A:N.185, A:T.285

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Branden, G. et al., Structure-based ligand design to overcome CYP inhibition in drug discovery projects. Drug Discov Today (2014)

Release Date

2014-08-13

Peptides

Cytochrome P450 2C9: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Cytochrome P450 2C9

Related Entries With Identical Sequence